According to Alkermes's latest financial reports the company's total debt is $0.37 B. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2023-12-31 | $0.37 B | -1.91% |
2022-12-31 | $0.37 B | -8.83% |
2021-12-31 | $0.41 B | 1.47% |
2020-12-31 | $0.41 B | 40.97% |
2019-12-31 | $0.29 B | 4.17% |
2018-12-31 | $0.27 B | -0.76% |
2017-12-31 | $0.28 B | -0.79% |
2016-12-31 | $0.28 B | -18.94% |
2015-12-31 | $0.34 B | -1.63% |
2014-12-31 | $0.35 B | |
2013-03-31 | $0.36 B | -16.98% |
2012-03-31 | $0.44 B | |
2010-03-31 | $51.04 M | -32.74% |
2009-03-31 | $75.88 M | -52.68% |
2008-03-31 | $0.16 B | 1.2% |
2007-03-31 | $0.15 B | -43.68% |
2006-03-31 | $0.28 B | 1.37% |
2005-03-31 | $0.27 B | 118.05% |
2004-03-31 | $0.12 B | -26.99% |
2003-03-31 | $0.17 B | -21.39% |
2002-03-31 | $0.22 B | -0.43% |
2001-03-31 | $0.22 B |
Company | Total debt | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $29.33 B | 7,781.03% | ๐บ๐ธ USA |
Novartis NVS | $26.34 B | 6,979.28% | ๐จ๐ญ Switzerland |
Pfizer PFE | $70.84 B | 18,934.89% | ๐บ๐ธ USA |
Sanofi SNY | $20.36 B | 5,372.31% | ๐ซ๐ท France |
Bristol-Myers Squibb BMY | $41.46 B | 11,040.70% | ๐บ๐ธ USA |
AstraZeneca AZN | $28.62 B | 7,590.26% | ๐ฌ๐ง UK |
Zogenix ZGNX | N/A | N/A | ๐บ๐ธ USA |
Acorda Therapeutics
ACOR | $0.18 B | -50.00% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $20.15 B | 5,314.78% | ๐ฎ๐ฑ Israel |